Jian P. Qu
Hunan Key Laboratory Of The Research And Development Of Novel Pharmaceutical Preparations
Changsha, China
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 111 publications
Response to Letter to the Editor "Methodological Considerations on the Longitudinal Analysis of Polymyxin B‑Induced Kidney Injury" [Response to Letter].
Journal: Drug design, development and therapy
Published: July 21, 2026
Pharmacokinetic/pharmacodynamic target attainment of eravacycline in a liver transplant recipient with refractory VRE faecium infection.
Journal: Antimicrobial agents and chemotherapy
Published: May 28, 2026
Therapeutic Drug Monitoring of Aztreonam-Avibactam in Critically Ill Patients with CRKP Infections and Variable Renal Function: A Case Series.
Journal: International journal of antimicrobial agents
Published: May 05, 2026
Prospective evaluation of individualized vancomycin dosing based on a population pharmacokinetic model in patients with severe Gram-positive bacterial infection.
Journal: Frontiers in pharmacology
Published: April 10, 2026
From Initiation to Recovery: A Longitudinal Analysis of Polymyxin B-Induced Kidney Injury in Clinical Practice.
Journal: Drug design, development and therapy
Published: April 08, 2026
Comparative performance analysis of lead-free perovskite solar cells based on FASnI3, CsSnI3, KGeCl3, and CsGeI3 absorbers with optimized charge transport layers.
Journal: RSC advances
Published: March 25, 2026
Reply to the comment on "Prolonged versus short-term infusion of meropenem for the treatment of sepsis: a systematic review and meta-analysis".
Journal: International journal of surgery (London, England)
Published: December 22, 2025
Cerebrospinal fluid and plasma pharmacokinetics of ceftazidime/avibactam in a neurocritical patient with CRKP intracranial infection and augmented renal clearance.
Journal: JAC-antimicrobial resistance
Published: December 04, 2025
Bibliometric Analysis of White Matter Disease and Novel Drug Therapy.
Journal: Current neuropharmacology
Published: September 24, 2025
A disproportionality analysis of adverse events associated with omadacycline based on the FDA adverse event reporting system database.
Journal: The Journal of antimicrobial chemotherapy
Published: July 24, 2025
Super-enhancer inhibitors THZ2 and JQ1 reverse temozolomide resistance in glioblastoma by suppressing SE-driven SOX9 expression.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: May 15, 2025
Prolonged versus short-term infusion of meropenem for the treatment of sepsis: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: April 12, 2025
Last Updated: 09/26/2026